The blood testing company named Daniel Guggenheim, JD, as chief compliance officer. Formerly, he served as an assistant general counsel at San Francisco-based McKesson.
Dave Wurtz, who previously served as an executive at Waltham, Mass.-based Thermo Fisher Scientific, was appointed vice president of regulatory and quality.
Theranos said its board of directors also created a compliance and quality committee.
Theranos came under fire last October when the Food and Drug Administration issued a lab inspection reports claiming the company had used an unapproved medical device and lacked proper quality control procedures, both of which jeopardized patient health and safety.
More articles on leadership:
11 hospitals with great customer service
CS Mott Children’s Hospital embraces Pokémon GO to raise kids’ energy
15 healthcare companies on Fortune’s Global 500 list
